Clinical Trials UpdateCT.govClinical TrialThursday, October 15, 2026
Safety and Efficacy of Desensitization Therapy in Sensitized Participants Awaiting Heart Transplantation
1 min read·By E. Nolan Beckett, MD·Source: ClinicalTrials.gov
Clinical Trial Profile
NCT
NCT01769443
Phase
PHASE2
Status
TERMINATED
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
From The Cardiac Wire
Coronary [LANDMARK] NCT07871591 : TOP-CABG Trial Follow-up Extension (TOP-CABG FE).
Not yet recruiting, N/A phase, enrollment 2,290, sponsor China National Center for Cardiovascular Diseases.
Editor’s take pending for this article; this is the section commentary excerpt.
Source Abstract
The primary objective is to evaluate the efficacy of desensitization therapy, which includes VELCADE® (bortezomib) and plasmapheresis, on select sensitized patients awaiting heart transplantation.
Read the Original
Full article at ClinicalTrials.gov
Open at ClinicalTrials.gov →The Cardiac Wire summarizes; we link out to primary sources for verification.
More in Clinical Trials Update
- Clinical Trials Update· Journal of cardiothoracic and vascular anesthesiaSerratus Posterior Superior Intercostal Plane Block Versus Superficial Parasternal Intercostal Plane Block With Local Infiltration for Postoperative Analgesia in Open Cardiac Surgery: A Randomized Controlled Trial.
- Clinical Trials Update· British journal of anaesthesiaThe effect of near-infrared spectroscopy guided intraoperative care on neurocognitive and functional outcomes after cardiac surgery: a systematic review and meta-analysis of randomised controlled trials.
- Clinical Trials Update· JAMA surgerySafety and Efficacy of Acute Normovolemic Hemodilution in Female Patients: A Secondary Analysis of the ANH Trial.
Elsewhere in Today’s Issue
- Coronary Surgery· CureusMore Than Skin Deep: Loculated Pericardial Effusion Causing Localized Cardiac Tamponade Due to Cutibacterium acnes Pericarditis.
- Coronary Surgery· Frontiers in medicineThe red blood cell distribution width-to-albumin ratio and 28-day mortality in patients with severe cardiogenic shock: a retrospective cohort study based on MIMIC-IV with single-center external validation.
- Coronary Surgery· Frontiers in cardiovascular medicine4D-Micro: a tiered, testable framework for hemodynamic-tissue perfusion mismatch in cardiac surgery.